Burcon NutraScience Corporation

BU.TOTSXConsumer Defensive● Active

$2.05

+$0.07(+3.54%)

Market Cap$26019166

P/E Ratio—

52W High$5

52W Low$1.51

Avg Volume3K

Open$1.86

Beta2.90

Free Cash Flow Financials Revenue

Burcon NutraScience Corporation (BU.TO) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

BU.TO · free cash flow · updated Jun 8, 2026

Core FCF metrics

BU.TO · FCF · TTM · margin & CAGR

Free cash flow was −$5.8M for FY2025 (fiscal year ending 2025-03-31), up 1.5% year-over-year

FY2025 Free Cash Flow−$5.8M▲ +1.5% YoY

Trailing 12M (TTM)−$8.2Mtrailing 4 quarters sum

FCF Margin< −999%−$5.8M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

BU.TO · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$5.5M(0M)−$5.8M▲ +1.5%—

FY2024−$5.8M(0M)−$5.9M▲ +7.4%—

FY2023−$6.0M(0M)−$6.4M▲ +11.2%—

FY2022−$5.9M(1M)−$7.2M▼ 21.6%—

FY2021−$3.0M(3M)−$5.9M▼ 37.1%—

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

BU.TO · P/FCF · FCF yield · FCF per share

Burcon NutraScience Corporation (BU.TO) reported negative free cash flow of −$0.01B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-03-31

Cash flow statement summary

BU.TO · cash flow statement · operating / investing / financing

For FY2025, Burcon NutraScience Corporation generated −$5.5M in operating cash flow and spent 0M in capital expenditures, yielding −$5.8M in free cash flow.

Operating Activities

−$5.5M

Cash from core business operations

2025-03-31

Investing Activities

−$1.7M

CapEx, acquisitions & investments

2025-03-31

Financing Activities

+$10.2M

Buybacks, dividends & debt

2025-03-31

FCF FormulaOperating CF (−$5.5M) − |CapEx| (0M) = FCF (−$5.8M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Consumer Defensive)

BU.TO vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Burcon NutraScience CorporationYOU

BU.TO

−$5.8M+1.5%-1525.0%

Loss

The Procter & Gamble Company

$14.04B-15.0%16.7%

94%

Philip Morris International Inc.

$10.66B-1.0%26.2%

71%

Costco Wholesale Corporation

COST

$7.84B+18.2%2.8%

53%

The Coca-Cola Company

$5.30B+11.7%11.0%

35%

Consumer Defensive · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Burcon NutraScience Corporation (BU.TO) reported free cash flow of −$5.8M for FY2025 (fiscal year ending 2025-03-31), up 1.5% year-over-year.

Burcon NutraScience Corporation has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 15 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

BU.TO free cash flow · 8 questions

Burcon NutraScience Corporation free cash flow was −$5.8M for FY2025, up 1.5% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$8.2M.

BU.TO free cash flowBU.TO FCFBU.TO FCF 2025BU.TO free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Burcon NutraScience Corporation · Burcon NutraScience Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026